oxonic acid has been researched along with Dysphagia in 4 studies
Oxonic Acid: Antagonist of urate oxidase.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The plasma 5-FU level was measured, and adverse events appearing after administration were monitored." | 1.33 | [Pharmacokinetics and adverse event of TS-1 administered through gastrostomy]. ( Hasegawa, M; Hirano, K; Nakamura, K, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Imamura, Y | 1 |
| Kiyota, N | 1 |
| Ogawa, G | 1 |
| Akimoto, T | 1 |
| Fujii, M | 1 |
| Hanai, N | 1 |
| Iwae, S | 1 |
| Monden, N | 1 |
| Matsuura, K | 1 |
| Onozawa, Y | 1 |
| Hayashi, R | 1 |
| Tahara, M | 2 |
| Hirano, K | 1 |
| Nakamura, K | 1 |
| Hasegawa, M | 1 |
| Tsuji, H | 1 |
| Nagata, M | 1 |
| Inoue, T | 1 |
| Minami, T | 1 |
| Iwai, H | 1 |
| Ohnishi, S | 1 |
| Yukawa, H | 1 |
| Ogura, M | 1 |
| Yamashita, T | 1 |
| Nagata, K | 1 |
3 trials available for oxonic acid and Dysphagia
| Article | Year |
|---|---|
Nutritional support dependence after curative chemoradiotherapy in head and neck cancer: supplementary analysis of a phase II trial (JCOG0706S1).
Topics: Adult; Aged; Anemia; Chemoradiotherapy; Cisplatin; Deglutition Disorders; Drug Combinations; Female; | 2019 |
[Clinical phase I trial of concurrent chemo-radiotherapy with S-1 for T2NO glottic carcinoma].
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Combined Modality Therapy; Deglutit | 2006 |
[Concurrent chemoradiotherapy (CRT) with S-1 and cisplatin (CDDP) in patients (pts) with locally advanced head and neck cancer (HNC)].
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cispl | 2006 |
1 other study available for oxonic acid and Dysphagia
| Article | Year |
|---|---|
[Pharmacokinetics and adverse event of TS-1 administered through gastrostomy].
Topics: Deglutition Disorders; Drug Administration Schedule; Drug Combinations; Fluorouracil; Gas Chromatogr | 2005 |